Federica Ilardi

Dr. Federica Ilardi

Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University Hospital, Via S. Pansini 5, 80131 Naples, Italy
+2
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2017 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
PLPatrizio Lancellotti
Patrizio Lancellotti
MGMaurizio Galderisi
Maurizio Galderisi
TEThor Edvardsen
Thor Edvardsen
EDErwan Donal
Erwan Donal
GGGeorg Goliasch
Georg Goliasch
Bogdan PopescuBogdan Popescu
Bogdan Popescu
The present Euro-Filling report aimed at comparing the diagnostic accuracy of the 2009 and 2016 echocardiographic grading algorithms for predicting invasively measured left ventricular filling pressure (LVFP). A total of 159 patients who underwent simultaneous evaluation of echo estimates of LVFP and invasive measurements of LV end-diastolic pressure (LVEDP) were enrolled at nine EACVI centres. Thirty-nine (25%) patients had a reduced LV ejection fraction (<50%), 77 (64%) were in NYHA ≥ II, and 85 (53%) had coronary artery disease. Sixty-four (40%) patients had elevated LVEDP (≥15 mmHg). Taken individually, all echocardiographic Doppler estimates of LVFP (E/A, E/e′, left atrial volume, tricuspid regurgitation jet velocity) were marginally correlated with LVEDP. By using the 2016 recommendations, 65% of patients with normal non-invasive estimate of LVFP had normal LVEDP, while 79% of those with elevated non-invasive LVFP had elevated invasive LVEDP. By using 2009 recommendations, 68% of the patients with normal non-invasive LVFP had normal LVEDP, while 55% of those with elevated non-invasive LVFP had elevated LVEDP. The 2016 recommendations (sensitivity 75%, specificity 74%, positive predictive value 39%, negative predictive value 93%, AUC 0.78) identified slightly better patients with elevated invasive LVEDP (≥ 15 mmHg) as compared with the 2009 recommendations (sensitivity 43%, specificity 75%, positive predictive value 49%, negative predictive value 71%, AUC 0.68). The present Euro-Filling study demonstrates that the new 2016 recommendations for assessing LVFP non-invasively are fairly reliable and clinically useful, as well as superior to the 2009 recommendations in estimating invasive LVEDP.

19 December 2018 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
RMRoberta Manganaro
Roberta Manganaro
SMStella Marchetta
Stella Marchetta
RDRaluca Dulgheru
Raluca Dulgheru
Federica IlardiFederica Ilardi
Federica Ilardi
TSTadafumi Sugimoto
Tadafumi Sugimoto
PLPatrizio Lancellotti
Patrizio Lancellotti
To obtain the normal ranges for 2D echocardiographic (2DE) indices of myocardial work (MW) from a large group of healthy volunteers over a wide range of ages and gender. A total of 226 (85 men, mean age: 45 ± 13 years) healthy subjects were enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study. Global work index (GWI), global constructive work (GCW), global work waste (GWW), and global work efficiency (GWE) were estimated from left ventricle (LV) pressure-strain loops. Peak LV systolic pressure was non-invasively derived from brachial artery cuff pressure. The lowest values of MW indices in men and women were 1270 mmHg% and 1310 mmHg% for GWI, 1650 mmHg% and 1544 mmHg% for GCW, and 90% and 91% for GWE, respectively. The highest value for GWW was 238 mmHg% in men and 239 mmHg% in women. Men had significant lower values of GWE and higher values of GWW. GWI and GCW significantly increased with age in women. The NORRE study provides useful 2DE reference ranges for novel indices of non-invasive MW.

16 June 2017 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
TSTadafumi Sugimoto
Tadafumi Sugimoto
RDRaluca Dulgheru
Raluca Dulgheru
ABAnne Bernard
Anne Bernard
Federica IlardiFederica Ilardi
Federica Ilardi
LCLaura Contu
Laura Contu
PLPatrizio Lancellotti
Patrizio Lancellotti
To obtain the normal ranges for 2D echocardiographic (2DE) measurements of left ventricular (LV) strain from a large group of healthy volunteers accounting for age and gender. A total of 549 (mean age: 45.6 ± 13.3 years) healthy subjects were enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study. 2DE data sets have been analysed with a vendor-independent software package allowing homogeneous measurements irrespective of the echocardiographic equipment used to acquire the data sets. The lowest expected values of LV strains and twist calculated as ± 1.96 standard deviations from the mean were −16.7% in men and −17.8% in women for longitudinal strain, −22.3% and −23.6% for circumferential strain, 20.6% and 21.5% for radial strain, and 2.2 degrees and 1.9 degrees for twist, respectively. In multivariable analysis, longitudinal strain decreased with age whereas the opposite occurred with circumferential and radial strain. Male gender was associated with lower strain for longitudinal, circumferential, and radial strain. Inter-vendor differences were observed for circumferential and radial strain despite the use of vendor-independent software. Importantly, no intervendor differences were noted in longitudinal strain. The NORRE study provides contemporary, applicable 2D echocardiographic reference ranges for LV longitudinal, radial, and circumferential strain. Our data highlight the importance of age- and gender-specific reference values for LV strain.

1 November 2018 in JAMA Cardiology
Verified
Journal Article
Closed access
PDF file
PLPatrizio Lancellotti
Patrizio Lancellotti
JMJulien Magne
Julien Magne
RDRaluca Dulgheru
Raluca Dulgheru
MCMarie-Annick Clavel
Marie-Annick Clavel
EDErwan Donal
Erwan Donal
COCécile Oury
Cécile Oury
In the western world, calcific aortic stenosis (AS), the most common valvular heart disease, represents a major public health burden.1 Currently, there is no pharmacological treatment that prevents or slows the progression of AS.2 Surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) are the only therapies to significantly improve both survival and symptoms3,4 and are recommended in symptomatic patients with severe AS.5,6 Quiz Ref ID The management of patients with asymptomatic severe AS, particularly the choice between early intervention vs watchful waiting, continues to be a matter of debate.7,8 Current guidelines advocate delaying AVR until symptoms or left ventricular (LV) systolic dysfunction develop.5,6 However, observational studies in 20109 and 201510 have suggested that early elective AVR might improve outcomes in patients with severe asymptomatic AS. This approach has been reinforced by continued advances in surgical techniques and aortic valve prostheses, the advent of TAVR, and the low perioperative mortality and morbidity rates achieved in valve centers of reference.11,12 However, preemptive surgery before onset of symptoms or LV systolic dysfunction is considered in only a selected group of patients after careful risk stratification. This is at least in part because the evidence for intervention in asymptomatic severe AS is derived from small, heterogeneous, retrospective, single-center studies, which have generally included the need for AVR (not always motivated by the development of symptoms or LV dysfunction) in the composite study end point.13-20 Moreover, decision making for AVR remains particularly difficult in older patients in whom it is sometimes unclear if the benefits of intervention outweigh the risk.5,6

23 February 2018 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
TSTadafumi Sugimoto
Tadafumi Sugimoto
SRSébastien Robinet
Sébastien Robinet
RDRaluca Dulgheru
Raluca Dulgheru
ABAnne Bernard
Anne Bernard
Federica IlardiFederica Ilardi
Federica Ilardi
PLPatrizio Lancellotti
Patrizio Lancellotti
To obtain the normal ranges for echocardiographic measurements of left atrial (LA) function from a large group of healthy volunteers accounting for age and gender. A total of 371 (median age 45 years) healthy subjects were enrolled at 22 collaborating institutions collaborating in the Normal Reference Ranges for Echocardiography (NORRE) study of the European Association of Cardiovascular Imaging (EACVI). Left atrial data sets were analysed with a vendor-independent software (VIS) package allowing homogeneous measurements irrespective of the echocardiographic equipment used to acquire data sets. The lowest expected values of LA function were 26.1%, 48.7%, and 41.4% for left atrial strain (LAS), 2D left atrial emptying fraction (LAEF), and 3D LAEF (reservoir function); 7.7%, 24.2%, and −0.53/s for LAS-active, LAEF-active, and LA strain rate during LA contraction (SRa) (pump function) and 12.0% and 21.6% for LAS-passive and LAEF-passive (conduit function). Left atrial reservoir and conduit function were decreased with age while pump function was increased. All indices of reservoir function and all LA strains had no difference in both gender and vendor. However, inter-vendor differences were observed in LA SRa despite the use of VIS. The NORRE study provides contemporary, applicable echocardiographic reference ranges for LA function. Our data highlight the importance of age-specific reference values for LA functions.

22 December 2016 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
ABAnne Bernard
Anne Bernard
KAKarima Addetia
Karima Addetia
RDRaluca Dulgheru
Raluca Dulgheru
LCLuis Caballero
Luis Caballero
TSTadafumi Sugimoto
Tadafumi Sugimoto
PLPatrizio Lancellotti
Patrizio Lancellotti
To obtain the normal ranges for 3D echocardiography (3DE) measurement of left ventricular (LV) volumes, function, and strain from a large group of healthy volunteers. A total of 440 (mean age: 45 ± 13 years) out of the 734 healthy subjects enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study had good-quality 3DE data sets that have been analysed with a vendor-independent software package allowing homogeneous measurements regardless of the echocardiographic machine used to acquire the data sets. Upper limits of LV end-diastolic and end-systolic volumes were larger in men (97 and 42 mL/m2) than in women (82 and 35 mL/m2; P < 0.0001). Conversely, lower limits of LV ejection fraction were higher in women than in men (51% vs. 50%; P < 0.01). Similarly, all strain components were higher in women than in men. Lower range was −18.6% in men and −19.5% in women for 3D longitudinal strain, −27.0% and −27.6% for 3D circumferential strain, −33.2% and −34.4% for 3D tangential strain and 38.8% and 40.7% for 3D radial strain, respectively. LV volumes decreased with age in both genders (P < 0.0001), whereas LV ejection fraction increased with age only in men. Among 3DE LV strain components, the only one, which did not change with age was longitudinal strain. The NORRE study provides applicable 3D echocardiographic reference ranges for LV function assessment. Our data highlight the importance of age- and gender-specific reference values for both LV volumes and strain.